Paper29617720
A decade of genome-wide association studies for coronary artery disease: the challenges ahead.
Erdmann J and 3 others. Cardiovasc Res, 2018. Cited by 288 papers, by iCite.
Cite this record
ConductScience Library. A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Papers, record 29617720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29617720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Artery Disease | Major topic |
| Genetic Markers | Major topic |
| Genetic Variation | Major topic |
| Genome-Wide Association Study | Major topic |
| Precision Medicine | Major topic |
| Diffusion of Innovation | |
| Forecasting | |
| Genetic Predisposition to Disease | |
| Heredity | |
| History, 21st Century | |
| Humans | |
| Pedigree | |
| Phenotype | |
| Predictive Value of Tests | |
| Prognosis | |
| Risk Factors |
Source PubMed
Cited by217
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 288 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979568 | Refining the genetic architecture of myocardial infarction through integrative post-genome-wide association study functional genomics analysis. | Bioinform Adv | 2026 | https://conductscience.org/library/papers/42979568 | PubMed |
| 42761943 | Cholesterol: Facts and Opinions by a Non-lipid Cardiologist. | Methodist Debakey Cardiovasc J | 2026 | https://conductscience.org/library/papers/42761943 | PubMed |
| 42761677 | Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD. | Methodist Debakey Cardiovasc J | 2026 | https://conductscience.org/library/papers/42761677 | PubMed |
| 42760933 | Identification of novel and known variants in GAA, MYH6, NEXN, ATA3A, RHBDF1, and ACTA1 genes in coronary artery disease patients by Whole-exome sequencing. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42760933 | PubMed |
| 42502157 | Interaction of a genetic sum score of risk alleles associated with coronary artery disease by physical activity in the Heinz Nixdorf Recall study. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/42502157 | PubMed |
| 42403454 | Use of a polygenic risk score to enhance early detection of coronary atherosclerosis. | Am J Prev Cardiol | 2026 | https://conductscience.org/library/papers/42403454 | PubMed |
| 42051566 | Multi-trait and Gene-Based Analyses Identify Genetic Variants Associated with Spontaneous Coronary Artery Dissection. | medRxiv | 2026 | https://conductscience.org/library/papers/42051566 | PubMed |
| 41983287 | Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype. | Circ Res | 2026 | https://conductscience.org/library/papers/41983287 | PubMed |
| 41894294 | The association between lipid metabolism and coronary artery disease: A systematic Mendelian randomization study combined with transcriptome analysis. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41894294 | PubMed |
| 41892715 | Genome-Wide Association Studies of Myocardial Infarction: A Systematic Literature Review. | J Cardiovasc Dev Dis | 2026 | https://conductscience.org/library/papers/41892715 | PubMed |
| 41844614 | Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk. | Nat Commun | 2026 | https://conductscience.org/library/papers/41844614 | PubMed |
| 41742042 | A novel simulation tool for low-coverage whole-genome sequencing using multivariate Gaussian mixture models. | BMC Bioinformatics | 2026 | https://conductscience.org/library/papers/41742042 | PubMed |
| 41673472 | Inherited risk of coronary artery disease: redefining care with imaging and genetics. | Nat Rev Cardiol | 2026 | https://conductscience.org/library/papers/41673472 | PubMed |
| 41660524 | Selected Genes Associated With CVD-Related Diseases, Pathways, and Nutrigenetics. | J Lipid Atheroscler | 2026 | https://conductscience.org/library/papers/41660524 | PubMed |
| 41648216 | Allelic Variation at 9p21.3 Orchestrates Widespread RNA Splicing Shifts Governing Vascular Smooth Muscle Cell Plasticity. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648216 | PubMed |
| 41644529 | Integrative functional genomics analysis identifies pleiotropic genes for vascular diseases. | Nat Commun | 2026 | https://conductscience.org/library/papers/41644529 | PubMed |
| 41381984 | Twin pairs discordant for incident coronary artery disease reveal epigenetic and transcriptomic differences by gene region. | Mol Genet Genomics | 2025 | https://conductscience.org/library/papers/41381984 | PubMed |
| 41098970 | Causal Relationship Between Genetically Determined Free Fatty Acids and Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study. | Int J Endocrinol | 2025 | https://conductscience.org/library/papers/41098970 | PubMed |
| 41057608 | Coronary artery disease-associated variants regulate vascular smooth muscle cell gene expression. | Nat Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41057608 | PubMed |
| 41010059 | GPBSO: Gene Pool-Based Brain Storm Optimization for SNP Epistasis Detection. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41010059 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29617720
GET https://conductscience.org/api/papers/v1/29617720/cited_by?page=2